Abbott Laboratories (ABT)

Abbott Laboratories (ABT) is a healthcare company (medical devices) based in the United States. The share price is $106.20, down 1.16% on the day, which values the company at $183.93B. Price as of 17 Nov 2026, 17:16 UTC, from Yahoo Finance.

Key facts

Share price
$106.20−1.16% today
Market value
$183.93B
P/E ratio
39.6×last 12 months
Forward P/E
17.9×
Dividend yield
2.35%
Funk Score
58/100
Against its own history
About its usual priceusual price $98.97
200-week average
$112.406% below

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Abbott Laboratories in more detail

ABT trades at 39.6× its last twelve months' earnings, 17.9× next year's expected earnings, 3.8× sales. Measured against its own history, the price is 7% above what its usual multiples would imply ($98.97) — about its usual price. It sits 6% below its 200-week average of $112.40.

Over the last five fiscal years Abbott Laboratories has compounded revenue 5.1% a year, earnings per share 8.3% a year, free cash flow 5.3% a year. Its Funk Score is 58 out of 100 (financial strength 8.1, profitability 6.3, growth 4.2, value 4.7, each out of 10).

In its favour: Altman Z in the safe zone.

15 of the superinvestors tracked here hold ABT, including Mason Hawkins (4.0% of the portfolio), Jensen team (2.4% of the portfolio), Diamond Hill team (2.2% of the portfolio).

Superinvestors holding ABT

15 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:ABT vs NVO (Abbott Laboratories vs Novo Nordisk)ABT vs GILD (Abbott Laboratories vs Gilead Sciences)ABT vs PFE (Abbott Laboratories vs Pfizer)ABT vs DHR (Abbott Laboratories vs Danaher)ABT vs ISRG (Abbott Laboratories vs Intuitive Surgical)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

Abbott Laboratories (ABT): questions and answers

What is ABT's P/E ratio?

Abbott Laboratories trades at 39.6× its last twelve months' earnings and 17.9× next year's expected earnings. At its fiscal year-ends over the past 19 years the P/E ranged from 7.8× to 211.4×, with a median of 28.1×.

What is ABT's PEG ratio?

Abbott Laboratories's PEG ratio is 1.55 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Abbott Laboratories's market cap?

Abbott Laboratories is valued at $183.93B at a share price of $106.20.

Is ABT overvalued or undervalued?

Against its own history, ABT is about its usual price: the price is 7% above the $98.97 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is ABT above its 200-week moving average?

No. ABT is 5.5% below its 200-week average of $112.40. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Abbott Laboratories growing?

Over the last five fiscal years Abbott Laboratories's revenue grew 5.1% a year and its earnings per share 8.3% a year; over ten years revenue grew 8.1% a year.

Cite this page

Funkfolio, “Abbott Laboratories (ABT) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ABT

Underlying data: Yahoo Finance; company filings with the SEC.